Design Cloud

  • Home

  • About Us

    Company Profile HIstory Culture Honor
    • Company Profile

    • HIstory

    • Culture

    • Honor

  • Products

    Cardiovascular series Psychiatry series Hepatobiliary, Gastroenterology Series Respiratory series Anti-infective virus series Other series Large Infusion Series Huabao Tong Series Active Pharmaceutical Ingredient Series
    • Cardiovascular series

    • Psychiatry series

    • Hepatobiliary, Gastroenterology Series

    • Respiratory series

    • Anti-infective virus series

    • Other series

    • Large Infusion Series

    • Huabao Tong Series

    • Active Pharmaceutical Ingredient Series

  • R&D

    Academician Expert Workstation Medical Research and Industry Alliance
    • Academician Expert Workstation

    • Medical Research and Industry Alliance

  • News

    General News Party group dynamics Employee activity
    • General News

    • Party group dynamics

    • Employee activity

  • HR

    Talent Strategy Company recruitment
    • Talent Strategy

    • Company recruitment

  • Contact us

  • 中文版

Image Name

News

  • Home page

General News

Party group dynamics

Employee activity

Wanbangde Pharmaceutical Group Co., Ltd. Announces Public Disclosure of the Environmental Impact Assessment for a New Project Producing 609 kg of Phloroglucinol Dihydrate Intermediate Annually

Date:

01 Mar,2021


The full text is attached. Click to download

Previous page

An invention patent has been authorized by the National Intellectual Property Administration.

The unique advantages of Shuguang Holy Land's Ginkgo Leaf Droplets spark lively discussions among experts and scholars.

Next page

Related Recommendations

Image Name

2022/10/12

Honors | Wanbangde Group Continues to Rank Among China's Top 500 Private Manufacturing Enterprises in 2022

Image Name

2022/10/12

United in purpose and rhythm, moving forward with collective strength— A recap of Wanbangde Pharmaceutical Group’s 2022 team-building activities for Quality, Administration, and HR.

Image Name

2022/10/12

Quality Month | Wanbangde Pharmaceutical Group Successfully Holds 2022 "Quality Month" Kickoff Event

< 1...343536...78 > proceed page
  • Home

  • About Us

    • Company Profile

    • HIstory

    • Culture

    • Honor

  • Products

    • Cardiovascular series

    • Psychiatry series

    • Hepatobiliary, Gastroenterology Series

    • Respiratory series

    • Anti-infective virus series

    • Other series

    • Large Infusion Series

    • Huabao Tong Series

    • Active Pharmaceutical Ingredient Series

  • R&D

    • Academician Expert Workstation

    • Medical Research and Industry Alliance

  • News

    • General News

    • Party group dynamics

    • Employee activity

  • HR

    • Talent Strategy

    • Company recruitment

  • Contact us

  • 中文版

Image Name

Website Development: China Enterprise DynamicsTaizhou

Business license
浙ICP备10002622号-38